Overview

PROSTACOX : Metastatic Prostate Chemotherapy

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Clinical response to chemotherapy. Biological parameter (PSA) and RECIST evaluation. Association of Docetaxel (J 15) and Celecoxib.
Details
Lead Sponsor:
University Hospital, Rouen
Treatments:
Celecoxib
Docetaxel